[go: up one dir, main page]

BR9911960A - Composição medicamentosa autoadesiva, e utilização da mesma - Google Patents

Composição medicamentosa autoadesiva, e utilização da mesma

Info

Publication number
BR9911960A
BR9911960A BR9911960-9A BR9911960A BR9911960A BR 9911960 A BR9911960 A BR 9911960A BR 9911960 A BR9911960 A BR 9911960A BR 9911960 A BR9911960 A BR 9911960A
Authority
BR
Brazil
Prior art keywords
self
adhesive
drug composition
weight
adhesive drug
Prior art date
Application number
BR9911960-9A
Other languages
English (en)
Other versions
BR9911960B1 (pt
Inventor
Achim Berthold
Walter M Ller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BR9911960A publication Critical patent/BR9911960A/pt
Publication of BR9911960B1 publication Critical patent/BR9911960B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/58Adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO MEDICAMENTOSA AUTOADESIVA, E, UTILIZAçãO DA MESMA". Uma composição medicamentosa autoadesiva para a aplicação transdérmica de um estrógeno em combinação com um gestágeno, contendo (a) 25-90 % em peso de um copolímero de acrilato autoadesivo, (b) 1-15 % em peso de um copolímero de acrilato formador de película, caracterizado por estarem contidos grupos funcionais de reação ácida, (c) 1-30 % em peso de aditivos acentuadores de pegajosidade, (d) 0,2-2,0 % em peso de estrógeno e (e) 1-5 % em peso de gestágeno.
BRPI9911960-9A 1998-07-09 1999-07-07 composição medicamentosa autoadesiva, e, utilização da mesma. BR9911960B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830651A DE19830651A1 (de) 1998-07-09 1998-07-09 Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
PCT/EP1999/004756 WO2000002540A1 (de) 1998-07-09 1999-07-07 Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung

Publications (2)

Publication Number Publication Date
BR9911960A true BR9911960A (pt) 2002-04-23
BR9911960B1 BR9911960B1 (pt) 2009-08-11

Family

ID=7873430

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9911960-9A BR9911960B1 (pt) 1998-07-09 1999-07-07 composição medicamentosa autoadesiva, e, utilização da mesma.

Country Status (23)

Country Link
EP (1) EP1093361B1 (pt)
JP (1) JP2002520271A (pt)
KR (1) KR100550889B1 (pt)
CN (1) CN1187042C (pt)
AR (1) AR019901A1 (pt)
AT (1) ATE238779T1 (pt)
AU (1) AU749850B2 (pt)
BR (1) BR9911960B1 (pt)
CA (1) CA2336654C (pt)
CZ (1) CZ299383B6 (pt)
DE (2) DE19830651A1 (pt)
DK (1) DK1093361T3 (pt)
ES (1) ES2201742T3 (pt)
HU (1) HUP0303553A3 (pt)
IL (2) IL140670A0 (pt)
MX (1) MXPA01000125A (pt)
NZ (1) NZ509214A (pt)
PL (1) PL192091B1 (pt)
RU (1) RU2218915C2 (pt)
TR (1) TR200100023T2 (pt)
TW (1) TW527197B (pt)
WO (1) WO2000002540A1 (pt)
ZA (1) ZA200100129B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
JP5021124B2 (ja) * 2001-08-29 2012-09-05 日東電工株式会社 医療用粘着組成物、それを用いた医療用粘着テープおよび経皮吸収用テープ製剤
DE10157745A1 (de) * 2001-11-24 2003-06-26 Hf Arzneimittelforsch Gmbh Transdermales therapeutisches System zur Verabreichung von 17alpha-Estradiol
ATE372772T1 (de) * 2004-07-13 2007-09-15 Schering Oy Retardiertes freigabesystem mit kontrollierter initialabgabe
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE4339400A1 (de) * 1993-11-18 1995-05-24 Hexal Pharma Gmbh Wirkstoffpflaster
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
FR2719770A1 (fr) * 1994-05-11 1995-11-17 Lhd Lab Hygiene Dietetique Système matriciel pour administration transdermique d'ibuprofène et procédé de préparation.
KR960009648A (ko) * 1994-08-29 1996-03-22 배순훈 텔레비전의 방송국명 표시장치
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen

Also Published As

Publication number Publication date
JP2002520271A (ja) 2002-07-09
TW527197B (en) 2003-04-11
ES2201742T3 (es) 2004-03-16
EP1093361B1 (de) 2003-05-02
CA2336654A1 (en) 2000-01-20
RU2218915C2 (ru) 2003-12-20
AR019901A1 (es) 2002-03-20
KR20010074644A (ko) 2001-08-04
EP1093361A1 (de) 2001-04-25
HUP0303553A3 (en) 2011-08-29
WO2000002540A1 (de) 2000-01-20
CZ299383B6 (cs) 2008-07-09
MXPA01000125A (es) 2002-06-04
TR200100023T2 (tr) 2001-07-23
AU749850B2 (en) 2002-07-04
NZ509214A (en) 2003-05-30
IL140670A (en) 2007-05-15
DK1093361T3 (da) 2003-08-25
AU5033299A (en) 2000-02-01
ZA200100129B (en) 2002-04-05
CN1308528A (zh) 2001-08-15
PL345537A1 (en) 2001-12-17
CN1187042C (zh) 2005-02-02
CZ200191A3 (en) 2001-05-16
ATE238779T1 (de) 2003-05-15
BR9911960B1 (pt) 2009-08-11
CA2336654C (en) 2007-10-16
IL140670A0 (en) 2002-02-10
HUP0303553A2 (hu) 2004-03-01
DE19830651A1 (de) 2000-01-13
DE59905337D1 (de) 2003-06-05
KR100550889B1 (ko) 2006-02-10
PL192091B1 (pl) 2006-08-31

Similar Documents

Publication Publication Date Title
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
ATE241990T1 (de) 3-beta-hydroxylierte natürliche steroidderivate enthaltende arzneimittelzusammensetzungen und ihre verwendung
BR9906920A (pt) "tts contendo um antioxidante"
HRP20070188A2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
FI962770A0 (fi) Transdermaalinen laite, joka sisältää polyvinyylipyrrolidonia liukoisuutta parantavana aineena
BR9812313A (pt) Sistema de liberação controlada de lìquido de viscosidade elevada como um dispositivo
BR0016166A (pt) Compostos de diidropirimidina heterocìclicos
ATE245450T1 (de) Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe
BR9609033B1 (pt) composição e emulsão para a liberação controlada de uma substáncia.
IL92007A0 (en) Pharmaceutical compositions containing gestodene
TR200002995T2 (tr) Folik asit ihtiva eden farmasötik bileşimler, bununla ilgili yöntemler ve uygulama sistemleri
KR910700044A (ko) 에스트로겐/프로게스틴 경피용량 단위, 시스템 및 방법
GT199700009AA (es) Terapia combinada para la osteoporosis
BR9810985A (pt) Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
PE20060853A1 (es) 18-metil-19-nor-17-pregn-4-en-21,17-carbolactonas, asi como preparaciones farmaceuticas que las contienen
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR0111678A (pt) Composições medicinais contendo derivados de propenona
MA26303A1 (fr) Compositions comprenant des resines organosiloxanes pour administration orale de substances de soins.
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
BR9911960A (pt) Composição medicamentosa autoadesiva, e utilização da mesma
BR0214159A (pt) Sistema farmacêutico radiopaco de liberação prolongada

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/70, A61K 31/56, A61K 47/30 A61L 15/22, A61L 15/28

Ipc: A61K 9/70 (2009.01)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 11.08.2019